Title:
USE OF AGOMELATINE FOR OBTAINING MEDICINE TREATING SMITH-MAGENIS SYNDROME
Document Type and Number:
Japanese Patent JP2008127395
Kind Code:
A
Abstract:
To provide a pharmacological composition for treating the Smith-Magenis syndrome that is an usual genetic disease caused by a tiny defect of chromosome.
One compound is selected from the group of agomelatine, namely [2-(7-methoxy-1-naphthyl)ethyl]acetamide that is represented by the formula, and its hydrate or adduct salts formed by combining with acid or base that are acceptable crystal or pharmacologically permissible one and only its own, or the combination thereof with one or more pharmacologicaly acceptable vehicles to obtain the pharmacological composition. Particularly, the use of agomelatine of the type II crystal is preferred.
Inventors:
MOCAER ELISABETH
FABIANO AGNES
FABIANO AGNES
Application Number:
JP2007302457A
Publication Date:
June 05, 2008
Filing Date:
November 22, 2007
Export Citation:
Assignee:
SERVIER LAB
International Classes:
A61K31/165; A61P25/14; A61P25/20; A61P43/00
Domestic Patent References:
| JP2005247844A | 2005-09-15 |
Attorney, Agent or Firm:
Hajime Tsukuni
Koshiro Tsukuda
Fusayuki Saito
Koshiro Tsukuda
Fusayuki Saito
Previous Patent: NOVEL AMIDE STRUCTURE-HAVING PYRIMIDINE COMPOUND AND MEDICINE CONTAINING THE SAME
Next Patent: FOAM AND ITS MANUFACTURING METHOD
Next Patent: FOAM AND ITS MANUFACTURING METHOD